Abstract:The SARS-CoV-2 pandemic has brought molecular biology and genomic sequencing into the public consciousness and lexicon. With an emphasis on rapid turnaround, genomic data informed both diagnostic and surveillance decisions for the current pandemic at a previously unheard-of scale. The surge in the submission of genomic data to publicly available databases proved essential as comparing different genome sequences offers a wealth of knowledge, including phylogenetic links, modes of transmission, rates of evolution, and the impact of mutations on infection and disease severity. However, the scale of the pandemic has meant that sequencing runs are rarely repeated due to limited sample material and/or the availability of sequencing resources, resulting in the upload of some imperfect runs to public repositories. As a result, it is crucial to investigate the data obtained from these imperfect runs to determine whether the results are reliable prior to depositing them in a public database. Numerous studies have identified a variety of sources of contamination in public next-generation sequencing (NGS) data as the number of NGS studies increases along with the diversity of sequencing technologies and procedures. For this study, we conducted an in silico experiment with known SARS-CoV-2 sequences produced from Oxford Nanopore Technologies sequencing to investigate the effect of contamination on lineage calls and single nucleotide variants (SNVs). A contamination threshold below which runs are expected to generate accurate lineage calls and maintain genome-relatedness and integrity was identified. Together, these findings provide a benchmark below which imperfect runs may be considered robust for reporting results to both stakeholders and public repositories and reduce the need for repeat or wasted runs. Large-scale genomic comparisons provide a wealth of knowledge, including modes of transmission, rates of evolution, and the impact of mutations on infection, disease severity, and treatment effectiveness. As a result, the public release of genomic data has proven crucial to response of the SARS-CoV-2 pandemic. However, studies continue to show that some of the genomic data in public repositories are contaminated from a variety of sources. For instance, the rapid response to the SARS-CoV-2 pandemic prevented many sequencing runs from being repeated, resulting in the occasional upload of imperfect runs to public repositories. It is of note that when genomic data is contaminated, both scientific decisions/studies and public health measures may be compromised. To identify genome contamination threshold(s) for SARS-CoV-2 sequences generated by Nanopore sequencing, computational biology techniques were used to generate artificially subsampled and contaminated libraries. This is the first study of its kind and we hope that the results obtained provide a starting point to investigate and report contamination for groups producing and analyzing NGS data.

Considerations for SARS-CoV-2 Genomic Surveillance: A Joint Consensus Recommendation of the Association for Molecular Pathology and Association of Public Health Laboratories

Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity.

Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: An Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program

Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology

Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights

Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance

Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern

Minimal requirements for ISO15189 validation and accreditation of three next generation sequencing procedures for SARS-CoV-2 surveillance in clinical setting

Recommendations for Uniform Variant Calling of SARS-CoV-2 Genome Sequence across Bioinformatic Workflows

Diagnostic Stewardship for Next-Generation Sequencing Assays in Clinical Microbiology: An Appeal for Thoughtful Collaboration

A response playbook for early detection and population surveillance of new SARS-CoV-2 variants in a regional public health laboratory

Next Generation Sequencing: Latent Applications in Clinical Diagnostics with the advent of Bioinformatic Frameworks

Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern

SARS-CoV-2 Wastewater Genomic Surveillance: Approaches, Challenges, and Opportunities

In silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences

Next Generation and Other Sequencing Technologies in Diagnostic Microbiology and Infectious Diseases

SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission

The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023)

Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing

Recommendations for Bioinformatics in Clinical Practice